Medicines Co. Stock
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicines Co. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medicines Co. | - | - | - | - | - | - | - |
Opko Health Inc. | 3.200% | 3.859% | 11.712% | 0.093% | -8.968% | -59.040% | -19.278% |
Catalent Inc. | 0.650% | -1.861% | -5.237% | 42.267% | 20.340% | -42.349% | 22.269% |
Repligen Corp. | -1.020% | -5.628% | -11.262% | -12.532% | -17.959% | -9.747% | - |
Comments
News
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, with a diverse product portfolio that includes pharmaceuticals, medical devices and consumer health products
Johnson & Johnson is as Cheap as it’s Going to Get
Shares of Johnson & Johnson (NYSE: JNJ) are as cheap as they will get. The stock is down in premarket trading following the Q1 release, but there is a bottom in play and reality to face. Trading